Abstract
Acyclovir is an acyclic purine nucleoside widely used as an antiviral agent with good topical efficacy. Acyclovir is a thermolabile drug, making it challenging to formulate a stable and effective emulsion via a conventional emulsification process. This study aims to develop, optimize, and characterize the nanoemulsion of thermolabile drug acyclovir, manufactured by adopting a cold emulsification process and compare the physicochemical properties and diffusion pattern with a leading marketed formulation. Diffusion studies were conducted using Franz diffusion cells. The optimized formulation was subjected to quantitative estimation of acyclovir, impurity profiling, viscosity, pH, vesicle size, shape, and polydispersibility index (PDI). In the current study, the particle size of the nanoemulsion varies from 66.25 to 244.40 nm, and the zeta potential revealed a high negative surface charge on the particles. Transmission electron microscopy images revealed spherical-shaped, non-aggregated, and discrete globules. The in-vitro diffusion study of acyclovir nanoemulsion showed enhanced penetration efficacy than the conventional emulsion. All these observations signified that the cold emulsification process for manufacturing nanoemulsion is appropriate for thermolabile and pH-sensitive drugs. The study demonstrates enhanced stability and efficacy of optimized acyclovir nanoemulsion through cold emulsification.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
